# Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

> **NCT00505882** · PHASE4 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Pramlintide
- **DRUG:** Glargine
- **DRUG:** Lispro
- **DRUG:** Aspart

## Key facts

- **NCT ID:** NCT00505882
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505882, "Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00505882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*